Search
for
Sort by
Research 241–270 of 1000+
- Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review
- Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen: A Phase III Research Study of Female Sexual Dysfunction in Women on Testosterone Patch Without Estrogen (APHRODITE)
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses
- Dermatologic Care of the Transplant Patient
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Cemiplimab-Induced Alopecia Areata
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Finasteride toxicity information: “limited”, “poor quality”, “biased”
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Ocular Events Temporally Associated With Minoxidil: A Structured Review
- Topical Eflornithine
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Systemic treatments for alopecia areata: A systematic review
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Comparison of Different Alpha-blocker Combinations in Male Hypertensives with Refractory Lower Urinary Tract Symptoms
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment